找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Methodology of the Evaluation of Psychotropic Drugs; Otto Benkert,Wolfgang Maier,Karl Rickels Conference proceedings 1990 Springer-Verlag

[復(fù)制鏈接]
樓主: 乳缽
41#
發(fā)表于 2025-3-28 15:46:04 | 只看該作者
42#
發(fā)表于 2025-3-28 22:00:40 | 只看該作者
43#
發(fā)表于 2025-3-28 23:42:20 | 只看該作者
National and International Guidelines for the Conduct of Clinical Trials of Psychotropic Drugs that even colleagues, who have been working on similar documents for years, seem much inclined to forget about so much existing printed material and restart the discussion from the zero point every time..
44#
發(fā)表于 2025-3-29 06:59:14 | 只看該作者
Statistical Issues: Sample Size and Dropouton in the design, and place great weight on the results of the contrast between placebo and standard. Thus, the first jump in the evolution of clinical trials design has usually been the “three cell” design (two actives and a placebo cell).
45#
發(fā)表于 2025-3-29 09:53:54 | 只看該作者
Diagnoses as Selection Criteria in Drug Trialsed the popularity of typological models (Strauss 1973, 1975, 1986) which reflect more the medical thinking in the form of categories (like health versus illness). Clinical practice in psychiatry also favors the use of diagnostic categories for indication and selection of patients for treatment.
46#
發(fā)表于 2025-3-29 12:07:09 | 只看該作者
Functional Classification and Response to Psychotropic Drugs syndrome” and then, due to the growing acceptance of DSM-III, to the major depressive episode. Now, even further indications for antidepressants, especially for panic disorder and generalized anxiety disorder, have been suggested.
47#
發(fā)表于 2025-3-29 16:11:31 | 只看該作者
48#
發(fā)表于 2025-3-29 20:12:36 | 只看該作者
49#
發(fā)表于 2025-3-30 01:15:43 | 只看該作者
for this, as well as for many other things, I will always be grateful. My father-in-law, the late Joseph Millstone, a man I dearly loved and respected, also provided me with support during the time I was working on this book. His death is for me an incalculable loss, and his memory is something I w
50#
發(fā)表于 2025-3-30 07:55:21 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 23:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
西林县| 瑞安市| 灵武市| 和田市| 贺州市| 汉阴县| 荥阳市| 邻水| 双江| 浦东新区| 宜兰市| 灌云县| 宣化县| 梅州市| 南丰县| 杂多县| 德令哈市| 台江县| 清苑县| 广平县| 阿拉尔市| 慈溪市| 连江县| 鄂伦春自治旗| 双江| 桂东县| 桃园县| 乐亭县| 罗城| 大关县| 南开区| 沂水县| 呼和浩特市| 北流市| 台中市| 余江县| 恩施市| 滨海县| 九江市| 长岛县| 黄平县|